Novartis Bioventures Ltd, 10% Owner at Ra Pharmaceuticals, Inc. (RARX), bought 84,954 shares at $13.00 ($1.1M) on 2016-10-31, disclosed to the SEC on 2016-10-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 339 | $4K | 0.4% |
| 2 | $13.00 | 84,615 | $1.1M | 99.6% |
| Total | $13.00 avg | 84,954 | $1.1M | 100% |
| Filing → |
| GRTX | SELL | 2020-06-04 | $251K | — | Filing → |
| BCYC | BUY | 2019-05-30 | $2.4M | — | Filing → |
| ARPO | SELL | 2019-04-15 | $185K | — | Filing → |